Cipla Shares
- All
- News
- Videos
-
Why Are Pharma Stocks Rising?
The recent decline in the stock market has unnerved investors and traders alike. But pharma stocks are rising. Find out why and other implications.
-
Here's Why Cipla Share Price Is Rising
Pharma stocks are in focus amid renewed fears of Covid outbreaks and have rallied between 5-15% in the past couple of days.
-
Stocks To Watch: Bajaj Auto, Cipla, Bank Of Baroda, JSW Steel
The domestic stock indices are likely to trade lower on Tuesday, taking cues from their global peers.
-
5 Promoters Who Sold Their Holding Before The Stock Market Selloff
As economic realities of high inflation and slowing growth set in, the BSE Sensex dropped more than 10% since its January 2022 peak
-
Sensex Slips Over 100 Points, Nifty Trades Below 17,300; Cipla, Wipro, Tech Mahindra Top Drags
The Indian equity indices on Friday traded lower led by selling pressure in information technology and pharma stocks during opening deals.
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Nifty Seen Opening Higher; Axis Bank, Kotak Bank, Cipla In Focus
Foreign institutional investors sold shares worth Rs 2,459 crore on Monday while domestic institutional investors bought shares worth Rs 2,390 crore.
-
Sensex, Nifty Set To Open Higher; Cipla, Steel Strips Wheels In Focus
Foreign institutional investors bought shares worth Rs 131 crore while domestic institutional investors sold shares worth Rs 613 crore on Friday.
-
Cipla Hits Record High On Pact To Import Moderna's Covid Vaccine
Cipla shares have so far this year surged 22 per cent compared with 10 per cent gain in the Sensex.
-
Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued
"Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India," Cipla said in a regulatory filing to the stock exchanges
-
Cipla Launches Covid-19 Detection Test Kit ; Shares Gain
Cipla launched ViraGen which is a real-time detection kit approved by the ICMR (Indian Council of Medical Research) and is based on multiplex PCR technology.
-
Cipla Gains Nearly 5% On Settlement of US Patent Litigation
Cipla share price jumps 5%: The pharma major has announced settlement of its patent litigation with Celgene Corporation, a wholly-owned subsidiary of Bristol Myers Squibb, in the United States
-
Stocks to Watch Today: UPL, KEC International, Cipla, Burger King
UPL shares may be on investor's radar after the company denied reports of SEBI initiating a forensic audit regarding whistleblower complaint
-
Share Market Updates: Sensex Rises Over 250 Points, Nifty Firm Above 11,950 Amid Broad-Based Gains
Share Market Updates: Top gainers in the Nifty basket of 50 shares at the time were Tata Steel, Cipla, Indian Oil, Bharti Airtel and ICICI Bank.
-
Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US
The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent.
-
Why Are Pharma Stocks Rising?
The recent decline in the stock market has unnerved investors and traders alike. But pharma stocks are rising. Find out why and other implications.
-
Here's Why Cipla Share Price Is Rising
Pharma stocks are in focus amid renewed fears of Covid outbreaks and have rallied between 5-15% in the past couple of days.
-
Stocks To Watch: Bajaj Auto, Cipla, Bank Of Baroda, JSW Steel
The domestic stock indices are likely to trade lower on Tuesday, taking cues from their global peers.
-
5 Promoters Who Sold Their Holding Before The Stock Market Selloff
As economic realities of high inflation and slowing growth set in, the BSE Sensex dropped more than 10% since its January 2022 peak
-
Sensex Slips Over 100 Points, Nifty Trades Below 17,300; Cipla, Wipro, Tech Mahindra Top Drags
The Indian equity indices on Friday traded lower led by selling pressure in information technology and pharma stocks during opening deals.
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Nifty Seen Opening Higher; Axis Bank, Kotak Bank, Cipla In Focus
Foreign institutional investors sold shares worth Rs 2,459 crore on Monday while domestic institutional investors bought shares worth Rs 2,390 crore.
-
Sensex, Nifty Set To Open Higher; Cipla, Steel Strips Wheels In Focus
Foreign institutional investors bought shares worth Rs 131 crore while domestic institutional investors sold shares worth Rs 613 crore on Friday.
-
Cipla Hits Record High On Pact To Import Moderna's Covid Vaccine
Cipla shares have so far this year surged 22 per cent compared with 10 per cent gain in the Sensex.
-
Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued
"Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India," Cipla said in a regulatory filing to the stock exchanges
-
Cipla Launches Covid-19 Detection Test Kit ; Shares Gain
Cipla launched ViraGen which is a real-time detection kit approved by the ICMR (Indian Council of Medical Research) and is based on multiplex PCR technology.
-
Cipla Gains Nearly 5% On Settlement of US Patent Litigation
Cipla share price jumps 5%: The pharma major has announced settlement of its patent litigation with Celgene Corporation, a wholly-owned subsidiary of Bristol Myers Squibb, in the United States
-
Stocks to Watch Today: UPL, KEC International, Cipla, Burger King
UPL shares may be on investor's radar after the company denied reports of SEBI initiating a forensic audit regarding whistleblower complaint
-
Share Market Updates: Sensex Rises Over 250 Points, Nifty Firm Above 11,950 Amid Broad-Based Gains
Share Market Updates: Top gainers in the Nifty basket of 50 shares at the time were Tata Steel, Cipla, Indian Oil, Bharti Airtel and ICICI Bank.
-
Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US
The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent.
